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Abstract
Background: Clinical assessment of depression is an important part of pre-surgical assessment among individuals
with morbid obesity. However, there is no agreed-upon instrument to identify mood psychopathology in this
population. We examined the reliability and criterion validity of the clinician-administered Montgomery-Åsberg
Depression Rating Scale (MADRS) and the utility of a short version for bariatric surgery candidates.
Methods: The sample was 374 patients with obesity, consecutively recruited from the waiting list of a bariatric
surgery clinic of University Hospital, Brazil: women 80 %, mean BMI 47 kg/m2, mean age 43.0 years. The 10-item
MADRS was analyzed against the SCID-I. Items that showed small relevance to sample’s characteristics and contribution
to data variability were removed to develop the short 5-item version of scale. We calculated the sensitivity
and specificity of cutoff points of both versions MADRS, and values were plotted as a receiver operating characteristic
curve.
Results: For the 10-item MADRS, the Cronbach’s alpha coefficient was 0.93. When compared against SCID-I,
the best cut-off threshold was 13/14, yielding sensitivity of 0.81 and specificity 0.85. Following items were
removed: reduced appetite, reduced sleep, concentration difficulties, suicide thought and lassitude. The 5-item
version showed an alpha coefficient of 0.94 and a best cut-off threshold of 10/11, yielding sensitivity of 0.81
and specificity 0.87. Similar overall ability to discriminate depression of almost 90 % was found for both 10-item and
5-item MADRS.
Conclusion: The MADRS is a reliable and valid instrument to assess depressive symptoms among treatment-seeking
bariatric patients. Systematic application of the abbreviated version of the MADRS can be recommended for enhancing
the clinical detection of depression during perioperative period.
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Background
Depression and obesity are onerous non-communicable
conditions that frequently coexist [1]. Depressive disorder
is one of the most common psychiatric comorbidities
among patients with severe obesity (BMI > 40 kg/m2), in
the pre- and the post-surgical period [2, 3]. Potential bi-
directional relationship between obesity and depression is
observed and possible causal relationship between these
conditions is suggested [4]. Although pre-surgery depres-
sion alone has not been shown to be a robust outcome
predictor of post-operative weight loss [5], its presence in
pre-surgical period can contraindicate bariatric procedure
[6]. Therefore, the accurate identification of psychopath-
ology is a crucial step in these patients.
Most of bariatric clinicians acknowledge that depression
should be treated and stabilized before surgery, but there
are problems in its detection. Non-recognition of depres-
sive symptoms can result in misdiagnosis [7] and unreli-
able judgment of surgical eligibility [8]. Moreover, many
patients tend to present themselves in positive light during
psychosomatic evaluations, highlighting somatic symp-
toms to meet medical expectations and clinical guidelines
of pre-surgical assessment. This impression management
represents an effort to control or influence the perceptions
of healthcare staff in the approval process [6, 9].
The performance of symptomatic scales of depression
can be altered when somatic and cognitive symptoms
co-occur alongside of depressive symptoms [9], what can
also lead to misclassification and mistakes in surgical indi-
cation. While overdetection of depression can increase
disapprovals to bariatric surgery [6, 9], its underdetection
can cause unfavorable outcome among unrecognized
depressive patients in post-surgical periods [10]. Thus,
the adoption of accurate methods displaying accept-
able sensitivity and specificity to identify perioperative
psychopathology can reduce the burden of depression
among bariatric patients [11].
Some popular instruments for detection of depression
were used in this population, e.g., the Hamilton Depres-
sion Rating Scale – HAM-D [12, 13], the Beck Depression
Inventory - BDI [9, 14–20], the Hospital Anxiety and De-
pression Scale - HADS [21–23], and the Patient Health
Questionnaire - PHQ [20, 24, 25]. Most of tools are self-
administered for screening depression and some re-
searchers claim that these scales are conceptually flawed
for use in specific settings and patients [9, 13, 26], with
several psychometric limitations (e.g., poor reliability or
validity) unsuitable to determine bariatric surgery.
Among available self-report scales, the BDI is the
most common one reported with the purpose of pre-
surgical screening for depression among obese popula-
tions [9, 15–20]. However, self-reporting instruments
like the BDI yield low level of depressive symptoms
and significant proportion of false-positive cases [15],
due to patient’s characteristics and response style in
bariatric setting during preoperative assessment [9].
The HADS does not include somatic symptoms and is
viewed as an easy tool to administer in this population;
this instrument has being adopted as indicator of psy-
chopathology in a large prospective Swedish Obese
Subjects (SOS) trial [22]. Nevertheless, its applicability
can be questioned for discriminating depressive illness,
as this tool has presented low sensitivity among breast
cancer participants [26].
Structured clinician-administered scales for depression
have not been well studied in bariatric population. In
comparison to the HAM-D, the Montgomery–Åsberg
Depression Rating Scale - MADRS [27] encompasses
limited number of somatic symptoms. Moreover, the de-
cision for choosing MADRS instead of HAM-D eventu-
ally rest on consensus that a useful instrument should
capture adequately the construct of depression among
patient samples [11], with empirical evidence of psycho-
metric robustness and cost-effectiveness [28].
Given the need for standardized assessment tools that
have validity evidence in bariatric population and clinician-
administered scales for depression have not been well stud-
ied in this population, we investigated the applicability of
the MADRS for a sample of pre-surgical patients in the
waiting list of a bariatric clinic. The MADRS has never
been applied to preoperative bariatric candidates and
incorporates a structured interview embedded in a brief
10-item scale [29]. We aimed to determine the accuracy of
the scale (a) to estimate its reliability and validity for asses-
sing depression, and (b) to test whether it is possible to
develop a short version of instrument without somatic-
cognitive symptoms.
Methods
This validation study determined the performance of the
MADRS for assessing depression among patients seeking
bariatric surgery.
Sampling and recruitment
The participants were recruited from a University-based
bariatric center in Brazil and should meet the criteria of
class III obesity (BMI ≥ 40 kg/m2) or class II (BMI ≥
35 kg/m2) with medical comorbidities. They were ranked
in a waiting list in accordance to admission date in the
program and clinical severity.
The first 500 eligible patients in the list were consecu-
tively invited by telephone to participate in the study.
After brief explanation, 63 patients declined to participate.
Additional 63 patients were excluded during the assess-
ment period due to: severe psychiatric illness (n = 2), pre-
vious bariatric surgery (n = 5), mobility difficulty (n = 37),
and incomplete interviews (n = 19). The final sample was
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comprised of 374 individuals, with a participation rate
of 74.8 %.
Table 1 shows the demographic characteristics of par-
ticipants. Of 374 participants, the majority were women
(79.9 %). Regarding marital status, half of them were
married/cohabiting (50.8 %), one-quarter was single
(25.4 %), the remaining was separated/divorced (16.8 %)
or widowed (7.0 %). The mean schooling was 9.6 years
of education (standard deviation [SD] 3.5), being 35.6 %
with 8 years and 44.9 % with 11 years. The mean age
was 43.0 years (SD 11.6) and the mean BMI was
47.0 kg/m2 (SD 7.1; range 31.2–92.1).
Instruments
a) Montgomery-Åsberg Depression Rating Scale
(MADRS) [27] investigates the presence of affective,
somatic, cognitive and behavioral symptoms of
depression. Ten symptoms are rated on a 0–6 scale,
along the possible scores of 0–60. The total score
classifies the patients in levels of severity: normal or
absent 0–6; mild 7–19; moderate 20–34; and severe
35–60 [30]. We used the Portuguese version of
MADRS [31] with the aid of the Structured
Interview Guide for the MADRS (SIGMA) [29] to
assess the anchor points of each item. The raters
were clinical psychologists with experience in
bariatric patients, whose scores were calibrated in 3
consensus meetings. Previous psychometric study
[32] reported the intraclass correlation coefficient
(ICC) of the MADRS as acceptable for unipolar
depression, ranging between 0.83 and 0.86. These
interviewers were blind to patients’ psychiatric
diagnosis and rated independently depressive
symptoms from November 2010 to March 2012,
totaling 17 months. The duration of the SIGMA
ranged from 10 to 40 min, without refusal.
b) Structured Clinical Interview for DSM-IV Axis I
Disorder (SCID-I) [33] is a standardized semi-
structured interview generally accepted as gold
standard to make diagnosis of psychiatric disorders
[34]. From 2010 to 2012, participants were randomly
assigned to be face-to-face assessed by trained
psychologists with previous experience in obesity
and bariatric surgery, with an inter-rater kappa
estimated as 0.81 [35]. The duration of the interview
ranged from 60 to 90 min for the SCID-I. The
psychiatric diagnoses of this sample can be inspected
in Additional file 1: Table S1.
Statistical analysis
Descriptive analysis depicted mean MADRS item en-
dorsement rate, standard deviation (SD) and range. The
Pearson’s coefficient of variation (CV), Cronbach’s alpha
coefficient (α) and item commonality (h2) were calcu-
lated for each item and total score. Non-relevant symp-
toms were eliminated in accordance with following
rationale: (a) clinic wisdom, (b) item endorsement and
(c) commonality values. To inspect the between-variable
structure of correlation, the dimensionality of the
MADRS was examined through factor analysis [36].
Subsequently, the signal detection analysis was per-
formed to establish the best cut-off point by adopting
the diagnosis of SCID-I/DSM-IV major depressive dis-
order as gold standard. The sensitivity and specificity,
the positive and negative predictive values (PPV/NPV)
were calculated for all possible thresholds. The Youden’s
index (γ) [37] was calculated to summarize the overall
misclassification. The Receiver Operating Characteristic
(ROC) curve was built by plotting data of sensitivity and
false-positive rates. The values of Area Under the Curve
(AUC) and their respective 95 % confidence intervals
(CI) were calculated.
All analyses were performed using SPSS version 20.0
and the level of significance was set at p < 0.05 for two-
tailed tests.
Results
Among 374 participants, 7 % (N = 26) met the criteria
for major depressive episode and 27.5 % (N = 103) life-
time major depression in accordance with SCID-I/DSM-
IV criteria. The mean total score of MADRS was 7.73
(SD 11.33, range 0–58, CV 1.47). The highest item en-
dorsement rates (mean score around 1.0) were observed
for ‘apparent sadness’ , ‘reduced sleep’ , ‘reported sadness’
and ‘inner tension’. The lowest endorsement rates
(mean < 0.75) were ‘suicidal thoughts’ , ‘reduced appetite’ ,
‘pessimistic thoughts’ and ‘concentration difficulties’.











8 years 133 35.6
11 years 168 44.9
15 years + 73 19.5
Mean age, years (S.D.) 43.0 (11.6)
Mean BMI, kg/m2 (S.D.) 47.0 (7.1)
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The items with the highest dispersion (CV > 2.0) were
‘suicidal thoughts’ , ‘reduced appetite’ and ‘pessimistic
thoughts’, indicating sizable response bias of score preci-
sion (Table 2). Although women scored higher than men
(8.08 vs. 6.33), high data dispersion has cancelled the
statistical difference between sexes (p = 0.23).
For the 10-item scale, the Cronbach’s alpha coefficient
was 0.93, showing adequate homogeneity. Item-total
correlation demonstrated that deleting any item would
affect slightly the internal consistency of the construct
(Cronbach’s alpha range 0.92–0.94). Conversely, the ana-
lysis of commonalities indicated that following somatic-
cognitive items explained smaller proportion of data
variability (h2 < 0.7), in decreasing order: ‘reduced appe-
tite’ , ‘reduced sleep’ , ‘suicidal thoughts’ , ‘concentration
difficulties’ and ‘lassitude’.
The sensitivity, specificity, PPV, NPV and best cut-off
point for scores of the 10-item and 5-item MADRS are
presented in Table 3. For 10-item MADRS, the best
trade-off threshold between sensitivity and specificity
was 13/14, yielding sensitivity 0.85 and specificity 0.81.
The PPV and NPV were 0.70 and 0.91, respectively. The
highest Youden’s index was γ = 0.66. Further analysis
showed that 23.8 % of participants scored above 13
points with mean score of 24.96 (25.1 % women and
18.7 % men).
The factor analysis demonstrated a unidimensional
structure of ‘general depression’ for MADRS, explained
63.4 % of data variability and salient factor loadings > 0.4
in all items (not shown). Because ‘reduced appetite’ , ‘re-
duced sleep’ and ‘suicidal thoughts’ showed lower com-
monalities (h2 < 0.5), and ‘concentration difficulties’ and
‘lassitude’ showed moderate commonalities (h2 < 0.7),
these somatic-cognitive items were sequentially removed
to develop short versions of scale. While ‘pessimistic
thoughts’ presented high CV of 2.14, its contribution to
the underlying construct was substantial (h2 = 0.74) and
was retained in the final version.
The 5-item version presented Cronbach’s alpha of 0.94
and showed comparable performance with 10-item ver-
sion, in terms of sensitivity and specificity (Table 3). For
the best threshold of 10/11, 19.0 % of the sample scored
above 10 points (19.4 % women and 17.3 % men).
The sensitivity and false-positive rates (1 - specificity)
were used to construct the ROC curve (Fig. 1). The area
under the curve (AUC) of 0.87 showed that the discrim-
inative accuracy of scale was satisfactory for both 10-
item and 5-item versions. Their respective CI95 % of
0.82–0.92 and 0.81–0.93 indicated substantial overlap
between two versions of the scale. In summary, these ac-
ceptable results indicated that the MADRS was appro-
priated for the detection of depression.
Discussion
Widely adopted in follow-up studies and clinical trials in
medical samples it is the first time that the applicability
of MADRS was psychometrically investigated among pa-
tients with severe obesity. We have shown that the
MADRS could be used with good confidence, high sen-
sitivity and specificity in this population. Also, this
clinician-administered scale could be customized into a
short version, preserving robust psychometric properties.
Accurate detection of depression and proper indication
of individuals to surgical intervention present a potential
impact for public health.
The majority of psychometric studies investigating
MADRS confirm its satisfactory reliability, with Cron-
bach’s alpha close to 0.8 and over [38]. Reliable pre-
operative evaluations may ensure the reproducibility of
pre-operative assessments and improve post-operative
outcomes [6, 8].
Where to place the cut-off point to determine the
presence of relevant depressive symptoms is critical to
the domain of public health. Among clinical studies on
MADRS, researchers reported the best threshold ranging
from 6 to 21. The large range of cut-off scores indicates
the need of validity investigation to ensure its applicabil-
ity for specific populations. Similar to present study,
three studies reported the best cut-off of 13/14 [39] for
neurodegenerative patients, one study recommended 6/7
for bipolar patients [40] and another 20/21 for geriatric
sample [41].
Concerning the severity level of depression, the mean
score of 7.7 could detect cases of “mild depression” [30].
Highly sensitive threshold of 6/7 can be recommended
for screening purpose in community studies.
Table 2 Mean, standard deviation (SD), coefficient of variation
(CV) of the Montgomery-Åsberg Depression Rating Scale (MADRS)
for severely obese patients (N = 374). Item-total correlation
and commonalities
Item Mean SD CV α h2
Apparent sadness 1.10 1.70 1.55 0.92 0.79
Reported sadness 0.99 1.72 1.74 0.92 0.77
Inner tension 0.94 1.47 1.56 0.92 0.71
Reduced sleep 1.00 1.63 1.63 0.93 0.41
Reduced appetite 0.48 1.08 2.25 0.94 0.33
Concentration difficulties 0.74 1.39 1.88 0.93 0.62
Lassitude 0.76 1.38 1.82 0.92 0.67
Inability to feel 0.76 1.45 1.91 0.92 0.81
Pessimistic thoughts 0.63 1.35 2.14 0.92 0.74
Suicidal thoughts 0.33 0.99 3.00 0.93 0.49
Total 7.73 11.33 1.47 0.93 0.63a
CV Pearson’s coefficient of variation = SD/Mean
α Cronbach’s alpha coefficient of internal consistency
h2 Commonality
aTotal percentage of data explained by unidimensional model of the MADRS
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Examining the threshold region between 6 and 9, the
scale still has detected cases of depression with substan-
tial sensitivity. However, the specificity of approximately
70 % along with lower PPV (<0.6) was of limited help to
identify active cases of depression. While the sensitivity
has slightly reduced in the region between 10 and 14,
substantial improvement in specificity was observed.
The recommended threshold for patients with severe
obesity should be 13/14 (mean score around 25), where
cases were classified as “moderate depression” with
higher specificity. This versatile performance of MADRS
can refer cases with different level of depression and set-
tings, for example, in pre-surgical period.
The clinician should be mindful of the disease and sam-
ple’s characteristics to interpret the scores of MADRS.
The tolerable number of cases of false-positives or false-
negatives should be taken into account. Particularly, the
low endorsement rate of ‘reduced appetite’ in patients
with obesity indicates that this symptom can decrease the
total score and the identification of depression in over-
eating individuals. Similarly, the inclusion of ‘suicidal idea-
tion’, which is infrequently observed among high BMI
Table 3 Sensitivity, specificity, positive and negative predictive values (PPV and NPV) and best cut-off point for scores of the 10-item
and 5-item MADRS
10-item MADRS
Cut-off 5/6 6/7 7/8 8/9 9/10 10/11 11/12 12/13 13/14a 14/15 15/16
Sensitivity 0.92 0.92 0.92 0.90 0.87 0.85 0.85 0.85 0.85 0.77 0.69
Specificity 0.64 0.66 0.69 0.70 0.74 0.76 0.77 0.81 0.81 0.83 0.84
PPV 0.52 0.56 0.56 0.57 0.59 0.60 0.62 0.69 0.70 0.72 0.72
NPV 0.95 0.95 0.95 0.94 0.93 0.92 0.92 0.91 0.91 0.86 0.82
γ 0.56 0.58 0.61 0.62 0.62 0.61 0.62 0.66 0.66 0.60 0.53
5-item MADRS
Cut-off 5/6 6/7 7/8 8/9 9/10 10/11a 11/12 12/13 13/14 14/15 15/16
Sensitivity 0.88 0.88 0.85 0.81 0.81 0.81 0.69 0.65 0.58 0.58 0.46
Specificity 0.75 0.76 0.81 0.85 0.86 0.87 0.88 0.90 0.90 0.90 0.93
PPV 0.57 0.56 0.61 0.70 0.71 0.75 0.74 0.78 0.76 0.76 0.81
NPV 0.71 0.94 0.94 0.91 0.91 0.90 0.85 0.82 0.79 0.79 0.72
γ 0.63 0.64 0.66 0.66 0.67 0.68 0.57 0.55 0.48 0.48 0.47
γ Youden’s index = (sensitivity + specificity) - 1
aMaximum trade-off between sensitivity and specificity
Bold-data: MADRS' threshold scores
Fig. 1 Receiver operating characteristics (ROC) curve and Area Under Curve (AUC) of the 10-item and 5-item MADRS for severely obese patients (N= 374)
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individuals [42], can lead to inconsistent assessment. If
these symptoms are included in the scale, many depressed
patients will go unnoticed and remain false-negative cases,
even they present clinical depression.
Clinical characteristics associated with obesity may ob-
scure the pattern of reported symptoms by this medical
population [43]. For example, obesity-related sleepiness
and fatigue are often described by overweight patients
and can be misinterpreted as depressive symptom by re-
spondents. Thus, the items ‘reduced sleep’ and ‘lassitude’
also was removed in the short version.
Considering the sample’s characteristics, most of par-
ticipants were waiting for years to undertake bariatric
surgery. Possibly, these eager patients have inclined to
respond to evaluation in order to appear positively ap-
propriate to do so [7]. This illness behavior may have
affected the truthfulness of answers to interviews regard-
ing the presence of psychopathology [2]. The suppos-
ition that some patients might have exaggerated,
disguised or minimized the severity of depressive symp-
toms is compatible with data dispersion of current inves-
tigation. This type of response bias can be minimized
with observer scales such as the MADRS and its stan-
dardized schedule SIGMA. Possible sex difference affect-
ing the performance of long and short version of the
MADRS should be tested in a larger size sample.
Finally, it is advocated that the retention of affective
symptoms can effectively identify depressive syndrome
with confidence and accuracy with the 5-item version.
Somatic-cognitive symptoms of depression should be
discarded during preoperative assessment of bariatric
patients [39]. The positive acceptance of the short scale
by the users, both patients and overloaded clinicians,
can increase the cost-effectiveness of assessment for in-
expensive implementation in bariatric clinics.
Limitations
Some limitations of this study should be considered before
generalizing the results of this investigation to population
with severe obesity. All participants were recruited from a
single university hospital, raising reservations about the
representativeness of participants. However, large sample
size and high participation rate support key findings of
our data.
Impression management operates among preoperative
bariatric patients and alters the results of symptomatic
scales and clinical interviews [2, 6, 8]. These patients
have produced imprecise responses (large SD and CV
indicators), suggesting that most of widely spread devia-
tions from the central tendency was due to their re-
sponse style. Although we have adopted rigorous SCID-I
interview and SIGMA schedule for assessing depression,
the social desirability bias can only be minimized, but
not completely ruled out [7]. In this context, higher
specificity of the face-to-face MADRS can curb the
proneness of false-positive cases observed in self-report
scales [9].
Although we have not directly compared competing
symptom scales in the same sample, available psycho-
metric indicators have shown that the MADRS outper-
forms the results of previous studies with the BDI in
bariatric patients [9, 15], yielding higher specificity and
lower misclassification rate. Detection of 87 % of cases
of depression [39] by MADRS seems to have reduced
the tendency of bariatric patients to mask their emo-
tional and physical symptoms [44]. Somatic-cognitive
complaints may increase the total BDI score, confound-
ing real medical complaints with depressive ones [9] and
reducing its clinical utility. In several instances, different
methodology of data collection [6] and adaptation of
psychometric tools [39] may be crucial to meet some
specific features of study population.
Conclusion
Systematic application of an instrument for assessing de-
pression in bariatric sample must be based on current
knowledge of patient’s illness behavior in clinical setting,
taking into account its psychometric utility and empir-
ical strength. Though there is no agreed-upon guideline
for assessing depression among patients with severe obes-
ity, formal mental health evaluation with reliable methods
before surgical procedure is recommended [11]. In line
with the literature, our investigation showed that the as-
sessment of depression among patients with severe obesity
is slippery and requires great caution, where independent
interviewers should disregard misleading somatic-cognitive
symptoms of depression during preoperative assessment of
bariatric surgery.
The forecast that both obesity and depression are epi-
demic conditions that will rise exponentially in next de-
cades challenges their proper identification as a medical
task of utmost interest. Both 10-item and 5-item version of
MADRS are effective tools in pre-operative bariatric evalu-
ation of depression, but the abbreviated scale which has
removed somatic-cognitive characteristics of treatment-
seeking individuals can redress intrinsic inadequacies of
the original scale. Systematic assessment with short version
of MADRS to detect depression, coordinated screening of
patient's weight and metabolic indicators are pivotal to en-
hance perioperative evaluations of patients with obesity
and improve their treatment outcome.
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